Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches

S Heymans, NK Lakdawala, C Tschöpe, K Klingel - The Lancet, 2023 - thelancet.com
Dilated cardiomyopathy is conventionally defined as the presence of left ventricular or
biventricular dilatation or systolic dysfunction in the absence of abnormal loading conditions …

Polyguluronic acid alleviates doxorubicin-induced cardiotoxicity by suppressing Peli1-NLRP3 inflammasome-mediated pyroptosis

E Zhang, C Shang, M Ma, X Zhang, Y Liu, S Song… - Carbohydrate …, 2023 - Elsevier
Polyguluronic acid (PG), a polysaccharide from alginate, possesses excellent bioactivities.
We prepared high-purity PG with 10.41 kDa molecular weight (Mw) and a 59 average …

Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function

X Zhu, X Wang, S Jiao, Y Liu, L Shi, Q Xu… - Acta Pharmacologica …, 2023 - nature.com
Clinically, cardiac dysfunction is a key component of sepsis-induced multi-organ failure.
Mitochondria are essential for cardiomyocyte homeostasis, as disruption of mitochondrial …

[HTML][HTML] Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions

C Huang, X Li, H Li, R Chen, Z Li, D Li, X Xu… - Journal of Translational …, 2024 - Springer
Doxorubicin (DOX) is a broad-spectrum and highly efficient anticancer agent, but its clinical
implication is limited by lethal cardiotoxicity. Growing evidences have shown that alterations …

[HTML][HTML] DoxoDB: A Database for the Expression Analysis of Doxorubicin-Induced LncRNA Genes

R Distefano, M Ilieva, JH Madsen, S Rennie, S Uchida - Non-coding RNA, 2023 - mdpi.com
Cancer and cardiovascular disease are the leading causes of death worldwide. Recent
evidence suggests that these two life-threatening diseases share several features in disease …

[HTML][HTML] The role of inflammation and antioxidant defenses in the cardiotoxicity of doxorubicin in elderly CD-1 male mice

A Reis-Mendes, M Ferreira, JA Duarte… - Archives of …, 2023 - Springer
Doxorubicin (DOX) is a potent chemotherapeutic agent used against several cancer types.
However, due to its cardiotoxic adverse effects, the use of this drug may be also life …

[HTML][HTML] RGS7 balances acetylation/de-acetylation of p65 to control chemotherapy-dependent cardiac inflammation

M Basak, K Das, T Mahata, D Kumar, N Nagar… - Cellular and Molecular …, 2023 - Springer
Cardiotoxicity remains a major limitation in the clinical utility of anthracycline
chemotherapeutics. Regulator of G-protein Signaling 7 (RGS7) and inflammatory markers …

Anthracycline cardiotoxicity is exacerbated by global p38β genetic ablation in a sexually dimorphic manner but unaltered by cardiomyocyte-specific p38α loss

SA George, A Kiss, KA Trampel… - American Journal …, 2023 - journals.physiology.org
Severe cardiotoxic effects limit the efficacy of doxorubicin (DOX) as a chemotherapeutic
agent. Activation of intracellular stress signaling networks, including p38 mitogen-activated …

[HTML][HTML] The Influence of Comorbidities on Chemokine and Cytokine Profile in Obstructive Sleep Apnea Patients: Preliminary Results

M Chaszczewska-Markowska, K Górna… - Journal of Clinical …, 2023 - mdpi.com
Introduction: Obstructive sleep apnea (OSA) is frequently associated with a chronic
inflammatory state and cardiovascular/metabolic complications. The aim of this study was to …

Upregulation of TRIM16 mitigates doxorubicin-induced cardiotoxicity by modulating TAK1 and YAP/Nrf2 pathways in mice

X Guo, M Liu, B Han, Y Zheng, K Zhang, G Bao… - Biochemical …, 2024 - Elsevier
The clinic application of doxorubicin (DOX) is severely limited by its severe cardiotoxicity.
Tripartite motif-containing protein 16 (TRIM16) has E3 ubiquitin ligase activity and is …